Taking on Trial Timelines in Atopic Dermatitis: Overcoming Obstacles to Site Selection & Patient Recruitment
Time: 11:00 am
day: Day Two
Details:
- Whilst an exciting time for novel drug development in Atopic Dermatitis, as understanding into unmet medical need through patient heterogeneity becomes clearer – as an increased number of trials take place, and patients naive to treatment more difficult to find in order to measure the efficacy of new treatments, challenges are posed to developers in operationally planning new trials
- With timelines being impacted, uncover how biopharma are approaching this challenge and regaining control of trial timelines to conserve resources and speed novel therapies towards regulatory